Medical therapy of acromegaly: Efficacy and safety of somatostatin analogues

Keyphrases

• Somatostatin Analogs 100%
• Medical Therapy 100%
• Growth Hormone Deficiency 42%
• Tumor Shrinkage 42%
• Growth Hormone 28%
• Primary Surgical Treatment 28%
• Radiotherapy 14%
• Cardiomyopathy 14%
• Comorbidity 14%
• Synergize 14%
• Prolonged Treatment 14%
• Treatment Options 14%
• Tumor Mass 14%
• Combination Therapy 14%
• Prospective Randomized Trial 14%
• Effects on Growth 14%
• Clinical Response 14%
• Tumor Resection 14%
• Treatment Choice 14%
• Chronic Disease 14%
• Increased Mortality 14%
• Growth Hormone Treatment 14%
• Primary Therapy 14%
• Transsphenoidal Surgery 14%
• Growth Hormone-secreting pituitary Adenoma 14%
• Optic chiasm 14%
• Perioperative Complications 14%
• Long-term Complications 14%
• Decompression 14%
• Somatostatin 14%
• Pasireotide 14%
• Pegvisomant 14%
• Long-acting Somatostatin Analogues 14%
• Lanreotide 14%
• Adenoma Size 14%
• Disease Control 14%
• Somatostatin Receptor Subtypes 14%
• Soluble Suppression of Tumorigenicity 2 (sST2) 14%
• Octreotide 14%
• Advanced Age 14%
• Surrounding Structures 14%
• Somatostatin Receptor 14%
• Biochemical Response 14%
• Microadenoma 14%
• Dopamine Agonist 14%
• Dopamine Receptor 14%
• Growth Hormone Receptor Antagonist 14%
• Motor Nerve 14%
• Arthrosis 14%
• Mass Control 14%
• Locomotor 14%
• Cardiovascular Atherosclerosis 14%
• Somatostatin Receptor Agonists 14%
• Chimeric Molecules 14%
• Surgical Cure 14%

Medicine and Dentistry

• Combination Therapy 100%
• Somatostatin Derivative 100%
• Acromegaly 100%
• Growth Hormone 62%
• Neoplasm 50%
• Somatostatin Receptor 25%
• Disease 12%
• Radiation Therapy 12%
• Adenoma 12%
• Atherosclerosis 12%
• Cancer Surgery 12%
• Chronic Disease 12%
• Physical Disease by Body Function 12%
• Cardiovascular System 12%
• Transsphenoidal Surgery 12%
• Growth Hormone Secreting Adenoma 12%
• Optic Chiasm 12%
• Peroperative Complication 12%
• Somatostatin 12%
• Octreotide 12%
• Receptor Subtype 12%
• Somatostatin Receptor 2 12%
• Pasireotide 12%
• Osteoarthritis 12%
• Agents Acting on the Eye 12%
• Angiopeptin 12%
• Microadenoma 12%
• Dopamine Agonist 12%
• Dopamine Receptor 12%
• Growth Hormone Receptor 12%
• Pegvisomant 12%
• Growth Hormone Release 12%
• Somatostatin Receptor Agonist 12%
• Motor Nerve 12%
• Hormone Receptor Blocking Agent 12%
• Comorbidity 12%
• Myocardial Disease 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Acromegaly 100%
• Somatostatin Derivative 100%
• Growth Hormone 75%
• Neoplasm 62%
• Somatostatin Receptor 25%
• Disease 12%
• Atherosclerosis 12%
• Adenoma 12%
• Pasireotide 12%
• Pegvisomant 12%
• Angiopeptin 12%
• Physical Disease by Body Function 12%
• Octreotide 12%
• Somatostatin Receptor 2 12%
• Receptor Subtype 12%
• Osteoarthritis 12%
• Peroperative Complication 12%
• Dopamine Receptor 12%
• Dopamine Receptor Stimulating Agent 12%
• Somatostatin 12%
• Chronic Disease 12%
• Growth Hormone Receptor 12%
• Hormone Receptor Blocking Agent 12%
• Agents Acting on the Eye 12%
• Microadenoma 12%
• Somatostatin Receptor Agonist 12%
• Growth Hormone Secreting Adenoma 12%
• Myocardial Disease 12%
• Comorbidity 12%